Effect of antenatal corticosteroids on survival for neonates born at 23 weeks of gestation

Obstetrics and Gynecology

Volumn 111, Issue 4, 2008, Pages 921-926

  Hayes, Edward J ^a   Paul, David A ^b   Stahl, Gary E ^b   Seibel Seamon, Jolene ^b   Dysart, Kevin ^b   Leiby, Benjamin E ^b   Mackley, Amy B ^b   Berghella, Vincenzo ^b  

^a Ben Franklin House   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; BIRTH WEIGHT; BRAIN HEMORRHAGE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN MORTALITY; PREGNANCY TERMINATION; PRENATAL EXPOSURE; PRENATAL PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STILLBIRTH;

BETAMETHASONE; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; INFANT, PREMATURE; LOGISTIC MODELS; MALE; OBSTETRIC LABOR, PREMATURE; ODDS RATIO; PREGNANCY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 41649091370     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318169ce2d     Document Type: Article

References (14)

1. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515-25.
2. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk for preterm birth. The Cochrane Database of Systematic Reviews 2006, Issue 3, Art. No.: CD004454.
3. National Institutes of Health. Report of the Consensus Development Conference on the effect of corticosteroids for fetal maturation on perinatal outcomes. Pub No. 95-3784. Bethesda (MD): U.S. Department of Health and Human Services, Public Health Service; 1994.
4. Jobe A. The respiratory system: Part 1. Lung development. In: Fanaroff A, Martin R, editors. Neonatal-perinatal medicine: diseases of the fetus and infant. 7th ed. St. Louis (MO): Mosby; 2002. p. 973-91.
5. Janvier A, Barrington KJ. The ethics of neonatal resuscitation at the margins of viability: informed consent and outcomes. J Pediatr 2005;147:579-85.
6. Wapner R. Antenatal corticosteroids: we continue to learn. Am J Obstet Gynecol 2004;190:875-6.
7. McElrath TF, Norwitz ER, Nour N, Robinson JN. Contemporary trends in the management of delivery at 23 weeks' gestation. Am J Perinatol 2002;19:9-15.
8. Perinatal care at the threshold of viability. ACOG Practice Bulletin No. 38. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;100:617-24.
9. Papile LA, Munsick-Bruno G, Schaefer A. Relationship of cerebral intraventricular hemorrhage and early childhood handicaps. J Pediatr 1983;103:273-7.
10. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1-7.
11. Hayes EJ, Paul D, Ness A, Mackley A, Berghella V. Very-low-birthweight neonates: do outcomes differ in multiple compared with singleton gestations? Am J Perinatol 2007;24:373-6.
12. Doyle LW, Kitchen WH, Ford GW, Rickards AL, Lissenden JV, Ryan MM. Effects of antenatal steroid therapy on mortality and morbidity in very low birth weight infants. J Pediatr 1986;108:287-92.
13. Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995;173:254-62.
14. Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, et al. NICHD Neonatal Research Network. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007;196:147.e1-8.